A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis
Chemotherapy typically destroys the tumor mass but rarely eradicates the cancer stem cells (CSCs) that can drive metastatic recurrence. A key current challenge is finding ways to eradicate CSCs and suppress their characteristics. Here, we report a prodrug, Nic-A, created by combining a carbonic anhy...
Na minha lista:
Principais autores: | , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2023
|
Acesso em linha: | https://doi.org/10.1073/pnas.2304081120 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|